A short Khavinson-family bioregulator peptide marketed for cortical (brain) tissue support — post-stroke recovery, cognitive decline, and TBI claims.

Is Cortagen authorised for neurological use?

No — not authorised by any major Western regulator. Post-stroke care has well-evidenced standards; Cortagen is not part of any clinical guideline.

Same single-research-group evidence pattern as the rest of the Khavinson family.

Cortagen — Peptidepedia

MOLECULAR INFORMATION

Cortagen is one of the Khavinson family of “short bioregulator peptides”.

Same single-source evidence pattern as the rest of the family.

What is Cortagen?: A short Khavinson-family bioregulator peptide marketed for cortical (brain) tissue support — post-stroke recovery, cognitive decline, and TBI claims.
Is Cortagen authorised for neurological use?: No — not authorised by any major Western regulator. Post-stroke care has well-evidenced standards; Cortagen is not part of any clinical guideline.
Why grade D?: Same single-research-group evidence pattern as the rest of the Khavinson family.